This result implies that C4 is involved in tumor malignancy, since CA125 is a common diagnostic marker for monitoring patients with ovarian cancer and the increase in CA125 level is generally associated with drug resistance and tumor progression [44]. This evidence concerns the gene MUC16 and ovarian carcinoma.